Effects of antipsychotics on fat deposition and changes in leptin and insulin levels
Open Access
- 2 January 2004
- journal article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 184 (1) , 58-62
Abstract
Background: Weight gain is a common consequence of antipsychotic drug treatment and can lead to further morbidity.Aims: To assess the effects of antipsychotic drug therapy on abdominal fat deposition, on insulin and leptin secretion, and on circulating glucose and lipids.Method: Abdominal body fat was determined by magnetic resonance imaging in a group of previously untreated patients with schizophrenia, before and after 10 weeks'antipsychotic drug treatment. Body mass and blood concentrations of glucose, insulin, leptin and lipids were also measured.Results: Significant increases in both subcutaneous and intra-abdominal fat were identified after antipsychotic drug treatment. A three-fold increase in leptin secretion as well as significant increases in levels of circulating lipids and non-fasting glucose were also identified.Conclusions: Patients first receiving antipsychotic drugs experience substantial deposition of both subcutaneous and intra-abdominal fat, reflecting a loss of the normal inhibitory control of leptin on body mass. Along with fat deposition, the increase in levels of fasting lipids and in non-fasting glucose may provide early signs of drug-induced progression towards the metabolic syndrome.Keywords
This publication has 15 references indexed in Scilit:
- H1-Histamine Receptor Affinity Predicts Short-Term Weight Gain for Typical and Atypical Antipsychotic DrugsNeuropsychopharmacology, 2003
- Weight gain and glucose and lipid metabolism disturbances during antipsychotic medicationEuropean Archives of Psychiatry and Clinical Neuroscience, 2002
- Antipsychotic-Induced Weight Gain and Therapeutic Response: A Differential AssociationJournal of Clinical Psychopharmacology, 2002
- The Concurrent Accumulation of Intra-Abdominal and Subcutaneous Fat Explains the Association Between Insulin Resistance and Plasma Leptin ConcentrationsDiabetes, 2002
- Abnormalities in Glucose Regulation During Antipsychotic Treatment of SchizophreniaArchives of General Psychiatry, 2002
- Atypical Antipsychotic???Induced Diabetes MellitusCNS Drugs, 2002
- Effects of long-term treatment with antipsychotics on serum leptin levelsThe British Journal of Psychiatry, 2001
- Antipsychotic-Induced Weight Gain: A Comprehensive Research SynthesisAmerican Journal of Psychiatry, 1999
- Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor geneNature Medicine, 1998
- The Positive and Negative Syndrome Scale (PANSS) for SchizophreniaSchizophrenia Bulletin, 1987